US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Array Digital Infrastructure Inc.

34.39

+0.22000.64%

Post-market: 34.390.00000.00%19:30 EDT

Volume:173.08K

Turnover:5.97M

Market Cap:2.97B

PE:5.56

High:35.20

Open:34.38

Low:34.32

Close:34.17

52wk High:60.82

52wk Low:33.12

Shares:86.38M

Float Shares:15.56M

Volume Ratio:0.65

T/O Rate:1.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):6.19

EPS(LYR):0.5551

ROE:22.68%

ROA:0.02%

PB:2.35

PE(LYR):61.96

Loading ...

Overview Company News Filings

Longeveron to Participate in Three Longevity/Aging Investment Conferences

Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026

Protecting Fading Memories: Taopu Town Pioneers a Dementia-Friendly Community

NYSE Order Imbalance 27881.0 Shares on Sell Side

THOMSON REUTERS

Digitus Group Qatari Subsidiary Signs Contract with Ooredoo Qatar

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid

Digitus Group Subsidiary Signs Addendum to Managed Services Agreement with Dubai's Du

New Topical Treatment Approval Signals Shift in Atopic Dermatitis Management Landscape

Digitus Group Appoints Kunal Dalmia as Group CFO

Micware Launches Growth Strategy Connecting Mobility and Digital Spaces with AI at its Core

Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference

CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)

CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Telephone & Data Systems (TDS) Stock Jumps Nearly 8% After Ending a Deal for Array Digital Infrastructure (AD)

Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses

Digitus Group Says Wissam Farhat Resigns as CFO

Annovis to Host Corporate Update Webinar on September 2, 2026

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Arcutis says Health Canada approves Zoryve cream 0.05% for children with AD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/AD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AD\",,,,,undefined,":{"symbol":"AD","market":"US","secType":"STK","nameCN":"Array Digital Infrastructure Inc.","latestPrice":34.39,"timestamp":1790971200000,"preClose":34.17,"halted":0,"volume":173083,"hourTrading":{"tag":"盘后","latestPrice":34.39,"preClose":34.39,"latestTime":"19:30 EDT","volume":2983,"amount":102585.37,"timestamp":1790983803713,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.006438396254023964,"floatShares":15563300,"shares":86379877,"eps":6.185934,"marketStatus":"Market Closed","change":0.22,"latestTime":"10-02 16:00:00 EDT","open":34.38,"high":35.2,"low":34.315,"amount":5974617.979649,"amplitude":0.0259,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.185934,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":34.17,"preHourTrading":{"tag":"盘前","latestPrice":34.2,"preClose":34.17,"latestTime":"06:19 EDT","volume":39,"amount":1340.799954,"timestamp":1790936392324,"change":0.03,"changeRate":0.000878,"amplitude":0.008194},"postHourTrading":{"tag":"盘后","latestPrice":34.39,"preClose":34.39,"latestTime":"19:30 EDT","volume":2983,"amount":102585.37,"timestamp":1790983803713,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6473165697725767,"impliedVol":0.4134,"impliedVolPercentile":0.884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AD\",,,,,undefined,":{"symbol":"AD","floatShares":15563300,"roa":"0.02%","roe":"22.68%","lyrEps":0.555055,"volumeRatio":0.6473165697725767,"shares":86379877,"dividePrice":0,"high":35.2,"amplitude":0.0259,"preClose":34.17,"low":34.315,"week52Low":33.12,"pbRate":"2.35","psRate":"13.91","week52High":60.82,"institutionHeld":0.3358,"latestPrice":34.39,"eps":6.185934,"divideRate":0,"volume":173083,"delay":0,"ttmEps":6.185934,"open":34.38,"prevYearClose":53.62,"prevWeekClose":34.49,"prevMonthClose":33.72,"prevQuarterClose":33.72,"fiveDayClose":34.49,"twentyDayClose":38.73,"sixtyDayClose":34.74,"dividendPayoutRate":40.52599213795753,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.4274298457535774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"AD","fiscalQuarterEnding":"2026/06","expectedEps":0.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":0.44},{"date":"2026-06-11","symbol":"AD","amount":11,"announcedDate":"2026-06-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-11","defaultRemindTime":1781184600000,"name":"Array Digital Infrastructure Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-25","payableDate":"2026-06-11","currency":"USD","dateTimestamp":1781150400000,"payDate":"2026-06-25"},{"market":"US","date":"2026-05-08","symbol":"AD","fiscalQuarterEnding":"2026/03","expectedEps":-0.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2026-02-20","symbol":"AD","fiscalQuarterEnding":"2025/12","expectedEps":0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771563600000,"reportTimeType":"pre","actualEps":0.48},{"date":"2026-01-23","symbol":"AD","amount":10.25,"announcedDate":"2026-01-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-23","defaultRemindTime":1769178600000,"name":"Array Digital Infrastructure Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-23","currency":"USD","dateTimestamp":1769144400000,"payDate":"2026-02-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AD\",market:\"US\",,,undefined,":[{"executeDate":"2025-08-20","recordDate":"2025-08-11","paymentDate":"2025-08-19","value":23,"currency":"USD"},{"executeDate":"2026-01-23","recordDate":"2026-01-23","paymentDate":"2026-02-02","value":10.25,"currency":"USD"},{"executeDate":"2026-06-11","recordDate":"2026-06-11","paymentDate":"2026-06-25","value":11,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.2,"hold":0.6,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1786420800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AD","date":"2026-10-02","current":5.559387,"percent":0.22807,"low":-273.92211,"twenty":-172.650208,"median":21.029345,"eighty":259.155968,"high":320.844562,"avg":54.604159,"sd":165.817576,"marketCap":2954987430},"quantilePoints":[{"date":"2025-08-15","current":-273.850129,"twenty":-273.893318,"median":-273.850129,"eighty":-273.612593,"marketCap":6572403103},{"date":"2025-08-22","current":-200.933798,"twenty":-273.763753,"median":-273.490226,"eighty":-228.502362,"marketCap":4822411161},{"date":"2025-08-29","current":-194.49692,"twenty":-273.591,"median":-200.933798,"eighty":-194.626488,"marketCap":4667926077},{"date":"2025-09-05","current":-189.890035,"twenty":-273.511821,"median":-195.360711,"eighty":-192.519268,"marketCap":4557360841},{"date":"2025-09-12","current":-184.671298,"twenty":-272.73443,"median":-194.119011,"eighty":-189.199003,"marketCap":4432111159},{"date":"2025-09-19","current":-175.349555,"twenty":-256.070925,"median":-192.368109,"eighty":-183.778715,"marketCap":4208389313},{"date":"2025-09-26","current":-169.950862,"twenty":-200.271577,"median":-189.74607,"eighty":-179.092649,"marketCap":4078820677},{"date":"2025-10-03","current":-180.892213,"twenty":-197.170296,"median":-184.671298,"eighty":-177.638601,"marketCap":4341413113},{"date":"2025-10-10","current":-180.028422,"twenty":-195.252737,"median":-184.059446,"eighty":-177.861746,"marketCap":4320682131},{"date":"2025-10-17","current":-179.200623,"twenty":-194.756057,"median":-183.555568,"eighty":-177.18511,"marketCap":4300814940},{"date":"2025-10-24","current":-177.581015,"twenty":-194.345757,"median":-180.586287,"eighty":-177.242697,"marketCap":4261944349},{"date":"2025-10-31","current":-176.105372,"twenty":-193.617663,"median":-180.892213,"eighty":-177.242697,"marketCap":4226528922},{"date":"2025-11-07","current":-171.642452,"twenty":-192.972746,"median":-180.010426,"eighty":-176.702827,"marketCap":4119418849},{"date":"2025-11-14","current":241.378582,"twenty":-192.09564,"median":-179.920448,"eighty":-175.407141,"marketCap":3917333000},{"date":"2025-11-21","current":240.473745,"twenty":-190.782619,"median":-179.452562,"eighty":-172.916544,"marketCap":3902648400},{"date":"2025-11-28","current":261.764027,"twenty":-189.890035,"median":-179.056658,"eighty":-170.850644,"marketCap":4248168400},{"date":"2025-12-05","current":265.117247,"twenty":-189.602105,"median":-178.588771,"eighty":240.420519,"marketCap":4302587800},{"date":"2025-12-12","current":265.543053,"twenty":-189.098227,"median":-177.958923,"eighty":244.409875,"marketCap":4309498200},{"date":"2025-12-19","current":274.059166,"twenty":-184.671298,"median":-177.329076,"eighty":249.043083,"marketCap":4447706200},{"date":"2025-12-26","current":286.620433,"twenty":-184.613712,"median":-177.149119,"eighty":260.390804,"marketCap":4651563000},{"date":"2026-01-02","current":285.396241,"twenty":-184.556126,"median":-176.681232,"eighty":261.913059,"marketCap":4631695600},{"date":"2026-01-09","current":277.199482,"twenty":-183.965869,"median":-175.78145,"eighty":263.648217,"marketCap":4498670400},{"date":"2026-01-16","current":297.372025,"twenty":-183.569965,"median":-174.161842,"eighty":266.266922,"marketCap":4826050600},{"date":"2026-01-23","current":320.844562,"twenty":-183.555568,"median":-173.981886,"eighty":271.994008,"marketCap":5206986400},{"date":"2026-01-30","current":252.1834,"twenty":-183.238845,"median":-172.02036,"eighty":268.321434,"marketCap":4092684400},{"date":"2026-02-06","current":257.665648,"twenty":-182.648588,"median":-169.950862,"eighty":267.224985,"marketCap":4181655800},{"date":"2026-02-13","current":269.109175,"twenty":-182.115917,"median":238.717297,"eighty":267.224985,"marketCap":4367372800},{"date":"2026-02-20","current":267.938209,"twenty":-181.48247,"median":240.926164,"eighty":268.704659,"marketCap":4348369200},{"date":"2026-02-27","current":255.643071,"twenty":-181.064971,"median":244.409875,"eighty":267.842403,"marketCap":4148831400},{"date":"2026-03-06","current":262.668864,"twenty":-180.769843,"median":247.365175,"eighty":267.342081,"marketCap":4262853000},{"date":"2026-03-13","current":255.643071,"twenty":-180.229973,"median":249.043083,"eighty":266.671437,"marketCap":4148831400},{"date":"2026-03-20","current":82.941723,"twenty":-180.021224,"median":248.376453,"eighty":265.819826,"marketCap":4043906649},{"date":"2026-03-27","current":82.498564,"twenty":-179.985233,"median":245.210832,"eighty":265.628214,"marketCap":4022299967},{"date":"2026-04-02","current":84.413012,"twenty":-179.95644,"median":244.199544,"eighty":265.543053,"marketCap":4115640834},{"date":"2026-04-10","current":87.513828,"twenty":-179.920448,"median":240.447132,"eighty":265.117247,"marketCap":4266824209},{"date":"2026-04-17","current":87.691125,"twenty":-179.920448,"median":236.588268,"eighty":264.265636,"marketCap":4275468504},{"date":"2026-04-24","current":86.627343,"twenty":-179.596527,"median":87.806368,"eighty":264.052733,"marketCap":4223602732},{"date":"2026-05-01","current":88.098909,"twenty":-179.308596,"median":87.655666,"eighty":263.999507,"marketCap":4295350384},{"date":"2026-05-08","current":87.40745,"twenty":-179.200623,"median":87.575882,"eighty":263.414024,"marketCap":4261637632},{"date":"2026-05-15","current":21.135166,"twenty":-178.912692,"median":87.337865,"eighty":263.147896,"marketCap":4402539647},{"date":"2026-05-22","current":21.338509,"twenty":-178.876701,"median":86.919883,"eighty":263.041444,"marketCap":4444896694},{"date":"2026-05-29","current":21.222313,"twenty":-178.646357,"median":86.396857,"eighty":262.74338,"marketCap":4420692667},{"date":"2026-06-05","current":21.55845,"twenty":-178.444805,"median":85.972934,"eighty":262.32822,"marketCap":4490711460},{"date":"2026-06-12","current":16.645033,"twenty":-178.17847,"median":85.475751,"eighty":262.157897,"marketCap":3467226884},{"date":"2026-06-18","current":16.18855,"twenty":-177.926531,"median":85.370237,"eighty":262.136607,"marketCap":3372139635},{"date":"2026-06-26","current":14.893798,"twenty":-177.667394,"median":85.086615,"eighty":261.913059,"marketCap":3102437619},{"date":"2026-07-02","current":15.151088,"twenty":-177.480239,"median":84.907561,"eighty":261.764027,"marketCap":3156032250},{"date":"2026-07-10","current":14.416565,"twenty":-177.285886,"median":83.339562,"eighty":261.593705,"marketCap":3003028221},{"date":"2026-07-17","current":14.495412,"twenty":-177.192309,"median":82.498564,"eighty":261.253061,"marketCap":3019452383},{"date":"2026-07-24","current":14.184174,"twenty":-177.005154,"median":82.259257,"eighty":261.061448,"marketCap":2954620167},{"date":"2026-07-31","current":14.516162,"twenty":-176.767611,"median":81.532476,"eighty":260.944352,"marketCap":3023774530},{"date":"2026-08-07","current":14.794201,"twenty":-176.56606,"median":80.513209,"eighty":260.8379,"marketCap":3081691310},{"date":"2026-08-14","current":5.765224,"twenty":-176.069381,"median":21.824041,"eighty":260.742094,"marketCap":3087300300},{"date":"2026-08-21","current":5.739385,"twenty":-175.867829,"median":21.55845,"eighty":260.635642,"marketCap":3073463660},{"date":"2026-08-28","current":5.731311,"twenty":-175.579899,"median":21.315684,"eighty":260.358869,"marketCap":3069139710},{"date":"2026-09-04","current":6.254541,"twenty":-175.112012,"median":21.259662,"eighty":260.252418,"marketCap":3349331670},{"date":"2026-09-11","current":6.144727,"twenty":-174.161842,"median":21.222313,"eighty":260.167256,"marketCap":3290525950},{"date":"2026-09-18","current":5.950938,"twenty":-174.08986,"median":21.116492,"eighty":259.475322,"marketCap":3186751150},{"date":"2026-09-25","current":5.56982,"twenty":-173.981886,"median":21.097818,"eighty":259.368871,"marketCap":2982660710},{"date":"2026-10-02","current":5.518143,"twenty":-172.650208,"median":21.029345,"eighty":259.155968,"marketCap":2954987430}],"updateTime":1791070772212},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672825977","title":"Longeveron to Participate in Three Longevity/Aging Investment Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2672825977","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672825977?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:05","pubTimestamp":1790798700,"startTime":"0","endTime":"0","summary":"New Data Analysis from Phase 2a Clinical Trial in Alzheimer’s Disease (AD) Indicating That Laromestrocel Treatment May Reduce Neuroinflammation in the Brain, A Core Driver of AD Pathogenesis, Publishe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3372378/0/en/longeveron-to-participate-in-three-longevity-aging-investment-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD","BK4150","MSC","BK4575","BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505082","title":"Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505082","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505082?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625900,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Sept.  28, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3370251/0/en/attovia-therapeutics-to-present-new-data-on-atto-1310-and-atto-2306-at-eadv-2026-and-fall-clinical-dermatology-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4143","BK4226","ATTO","BK4139","AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151991870","title":"Protecting Fading Memories: Taopu Town Pioneers a Dementia-Friendly Community","url":"https://stock-news.laohu8.com/highlight/detail?id=1151991870","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151991870?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:21","pubTimestamp":1789993318,"startTime":"0","endTime":"0","summary":"A simple phrase like \"I'm thirsty\" is, for most people, a basic expression of need, a request for a glass of water. But for some elderly individuals living with cognitive impairment, the link between...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994127","title":"NYSE Order Imbalance 27881.0 Shares on Sell Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994127","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994127?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:50","pubTimestamp":1789674600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nAQN2MJRKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643766","title":"Digitus Group Qatari Subsidiary Signs Contract with Ooredoo Qatar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643766","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643766?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:41","pubTimestamp":1789465261,"startTime":"0","endTime":"0","summary":"Sept 15 (Reuters) - DIGITUS GROUP FOR DIGITAL INFRASTRUCTURE, DATA CENTERS & COMMUNICATIONS KSCP::*DIGITUS GROUP - QATARI SUBSIDIARY SIGNS A CONTRACT WITH OOREDOO*DIGITUS GROUP - CONTRACT FOR IMPLEMEN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nRSD4G6XcW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TDS","BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667261696","title":"BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid","url":"https://stock-news.laohu8.com/highlight/detail?id=2667261696","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667261696?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:01","pubTimestamp":1789416060,"startTime":"0","endTime":"0","summary":"Conference call scheduled for Tuesday, September 15, 2026, at 8:30 a.m. Eastern Time (ET)CARSON CITY, Nev., Sept.  14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (\"BioVie\" or the \"Company\"), ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3361532/0/en/biovie-to-host-conference-call-to-discuss-topline-data-from-phase-2-address-lc-trial-and-the-potential-of-bezisterim-in-long-covid.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENFR","LU1169589451.USD","AD","BK4132","USAI","UMI","LU1169590202.USD","AMZA","EMLP","BK4023","BK4139","BK4588","ET","BK4561","EIPX","AMLP","BK4581","TNGY","TPZ","PD","BK4590","MDST","BK4585","BK4144","MLPA","EIPI","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657804","title":"Digitus Group Subsidiary Signs Addendum to Managed Services Agreement with Dubai's Du","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657804","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657804?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:05","pubTimestamp":1789380342,"startTime":"0","endTime":"0","summary":"Sept 14 (Reuters) - DIGITUS GROUP FOR DIGITAL INFRASTRUCTURE, DATA CENTERS & COMMUNICATIONS KSCP::*DIGITUS GROUP - UAE SUBSIDIARY SIGNS ANNEX TO EXISTING MANAGED SERVICES AGREEMENT WITH DU*DIGITUS GRO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nRSD6RkT9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","TDS","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165135911","title":"New Topical Treatment Approval Signals Shift in Atopic Dermatitis Management Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=1165135911","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165135911?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:26","pubTimestamp":1788956795,"startTime":"0","endTime":"0","summary":"On September 2, China Medical System Holdings Ltd (0867.HK), through its subsidiary Demei Pharma, received NMPA approval for ruxolitinib phosphate cream to add a new indication for atopic dermatitis...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TCS","BK4132","BK4200","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587027","title":"Digitus Group Appoints Kunal Dalmia as Group CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587027","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587027?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:27","pubTimestamp":1788953275,"startTime":"0","endTime":"0","summary":"Sept 9 (Reuters) - DIGITUS GROUP FOR DIGITAL INFRASTRUCTURE, DATA CENTERS & COMMUNICATIONS KSCP::*DIGITUS GROUP - APPOINTS KUNAL DALMIA AS GROUP CFO*Further company coverage: DIGITUS.KW* ((Reuters.Bri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nRSD21p2H7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD","TDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664363383","title":"Micware Launches Growth Strategy Connecting Mobility and Digital Spaces with AI at its Core","url":"https://stock-news.laohu8.com/highlight/detail?id=2664363383","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664363383?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:25","pubTimestamp":1788485100,"startTime":"0","endTime":"0","summary":"With its two platforms “micAuto” and “DynaPlanet”, Micware aims to evolve into a business where technology assets continuously create valueKOBE, Japan, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Micware Co.,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/04/3356354/0/en/micware-launches-growth-strategy-connecting-mobility-and-digital-spaces-with-ai-at-its-core.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","ARTY","AD","AIPO","VGT","BK4588","BK4097","AGIX","BK4132","MWC","VTHR","BK4585","CHAT","QQH","IGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877186","title":"Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877186","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877186?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":"MIAMI, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355999/0/en/longeveron-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD","BK4150","MSC","BK4575","BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664087717","title":"CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664087717","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664087717?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:08","pubTimestamp":1788437280,"startTime":"0","endTime":"0","summary":"SHENZHEN, CHINA, Sept.  03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355884/0/en/cms-867-hk-8a8-sg-innovative-drug-lumirix-approved-in-china-for-additional-indication-of-atopic-dermatitis-ad.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TCS","BK4132","BK4017","LU2488822045.USD","SG9999015986.USD","IE00BVYPNQ40.USD","LU1223083913.SGD","IE00BYV24P56.USD","SG9999015952.SGD","GDXJ","SG9999015978.USD","BK1191","LU1223082519.USD","LU1223082196.USD","IE00BGHQDM52.EUR","BK4200","IE00BVYPNP33.GBP","SGDM","IE00BMCWC346.EUR","AD","BK1593","SIL","CDE","SG9999004220.SGD","XME","SG9999015945.SGD","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176808711","title":"CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1176808711","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176808711?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:04","pubTimestamp":1788429862,"startTime":"0","endTime":"0","summary":"CMS (00867) has announced that its subsidiary, Demei Pharma, obtained approval from China's National Medical Products Administration (NMPA) on September 2, 2026, for the New Drug Application (NDA) of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","IBBQ","IPOS","LU2488822045.USD","00867","BK1574","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","SG9999015978.USD","LNGR","BK1593","BK1161","SG9999004220.SGD","IE00BGHQDM52.EUR","BK1191","SG9999015945.SGD","SG9999015986.USD","IE00BYV24P56.USD","159992","06978","AD","MEDX","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819849","title":"Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819849","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819849?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:00","pubTimestamp":1788379200,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amylo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355470/0/en/acumen-pharmaceuticals-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD","BK4539","BK4139","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144810","title":"Telephone & Data Systems (TDS) Stock Jumps Nearly 8% After Ending a Deal for Array Digital Infrastructure (AD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144810","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144810?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:44","pubTimestamp":1788360280,"startTime":"0","endTime":"0","summary":"Telephone & Data Systems stock was up nearly 8% on Wednesday after the company ended its bid to acquire Array Digital Infrastructure.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/telephone-data-systems-tds-stock-jumps-nearly-8-after-ending-a-deal-for-array-digital-infrastructure-ad?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/telephone-data-systems-tds-stock-jumps-nearly-8-after-ending-a-deal-for-array-digital-infrastructure-ad?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4132","TDS","DTCR","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664558698","title":"Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses","url":"https://stock-news.laohu8.com/highlight/detail?id=2664558698","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664558698?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"Enrollment completed in KT-621 BROADEN2 Phase 2b AD trial with topline data expected by year-end 2026; Phase 3 trials in AD planned to initiate by mid-2027 KT-621 BREADTH Phase 2b asthma trial ongoing","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353950/0/en/kymera-therapeutics-announces-presentations-on-kt-621-a-first-in-class-oral-stat6-degrader-at-the-european-respiratory-society-and-european-academy-of-dermatology-venereology-congr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006061336.USD","LU0541502299.USD","LU0320765646.SGD","LU1162221912.USD","LU0300736492.USD","LU0300736062.USD","BK4115","BPH","EPV","AD","BK4585","KYMR","LU0162691827.USD","SG9999004220.SGD","BK4588","LU0541501648.USD","BK4139","LU0072461881.USD","BK4132","KT","BK4096","BK4201","LU1829250122.USD","PN","BP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662569716","title":"Digitus Group Says Wissam Farhat Resigns as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662569716","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662569716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:58","pubTimestamp":1787745483,"startTime":"0","endTime":"0","summary":"Aug 26 (Reuters) - DIGITUS GROUP FOR DIGITAL INFRASTRUCTURE, DATA CENTERS & COMMUNICATIONS::*DIGITUS GROUP - WISSAM FARHAT RESIGNS AS CFO, EFFECTIVE AUG 31*Further company coverage: DIGITUS.KW* ((Reut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nRSD5gC5Mv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4132","TDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509732","title":"Annovis to Host Corporate Update Webinar on September 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509732","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Aug.  25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350406/0/en/annovis-to-host-corporate-update-webinar-on-september-2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4023","BK4585","LU1169590202.USD","HST","LU1169589451.USD","BK4588","AD","PD","BK4139","ANVS","BK4132","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661327966","title":"LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661327966","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661327966?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573040,"startTime":"0","endTime":"0","summary":"LEQEMBI IQLIK is the first-of-its-kind anti-amyloid treatment worldwide offering at-home dosing for initiation and maintenance (approved in the U.S.)TOKYO and CAMBRIDGE, Mass., Aug.  24, 2026 (GLOBE N","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349698/0/en/leqembi-iqlik-lecanemab-irmb-autoinjector-for-initiation-of-therapy-now-available-in-the-u-s-for-early-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4132","MCI","ARIA","CAA","CDR","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940239","title":"Arcutis says Health Canada approves Zoryve cream 0.05% for children with AD","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940239","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940239?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:30","pubTimestamp":1787247037,"startTime":"0","endTime":"0","summary":"Arcutis Canada announced that Health Canada has approved ZORYVE cream 0.05% for the topical treatment of mild to moderate atopic dermatitis in pedi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcutis-says-health-canada-approves-zoryve-cream-0-05-for-children-with-ad-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcutis-says-health-canada-approves-zoryve-cream-0-05-for-children-with-ad-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":170,"code":"91000000","status":"200"}]}}